| S. No. | Class | Drug | Company | Year of Approval | Remarks | ||
|---|---|---|---|---|---|---|---|
| Brand Name | Active Ingredient | ||||||
| 1 | NRTI | Retrovir | Zidovudine (AZT) | GSK | 1987 | ||
| 2 | NRTI | Epivir | Lamivudine (3TC) | GSK | 1995 | ||
| 3 | NRTI | Zerit | Stavudine (d4T) | BMS | 1994 | ||
| 4 | NRTI | Videx | Didanosine (ddl) | BMS | 1989 | ||
| 5 | NRTI | Videx EC | enteric coated didanosine (ddI EC) | BMS | 2000 | ||
| 6 | NRTI | Ziagen | Abacavir (ABC) | GSK | 1988 | ||
| 7 | NRTI | Viread | Tenovofir Disoproxil Fumarate (TDF) | Gilead | 2002 | ||
| 8 | NRTI | Emtriva | Emtricitabine (FTC) | Gilead | 2003 | ||
| 9 | NRTI | Trizivir | abacavir, zidovudine, and lamivudine (ABC, AZT and 3TC) | GSK | 2000 | 3NRTI | |
| 10 | NRTI | Combivir | lamivudine and zidovudine (3TC and AZT) | GSK | 1997 | 2 NRTI | |
| 11 | NRTI | Epzicom | abacavir and lamivudine (ABC and 3TC) | GSK | 2004 | 2 NRTI | |
| 12 | NRTI | Truvada | tenofovir disoproxil fumarate and emtricitabine (TDF and FTC) | Gilead | 2004 | 2 NRTI | |
| 13 | NNRTI | Viramune | Nevirapine (NVP) | BI | 1996 | ||
| 14 | NNRTI | Sustiva | Efavirenz (EFV) | BMS | 1998 | ||
| 15 | NNRTI | Rescriptor | Delavirdine (DLV) | Agouron | 2003 | ||
| 16 | NNRTI | Intelence | Etravirine | Tibotec | 2008 | ||
| 17 | NNRTI+NRTI | Atripla | efavirenz, emtricitabine and tenofovir disoproxil fumarate (EFV, FTC and TDF) | Gilead | 2006 | NNRTI+NRTI combination | |
| 18 | PI | Crixivan | Indinavir (IDV) | Merck | 1996 | ||
| 19 | PI | Viracept | Nelfinavir (NFV) | Agouron | 1997 | ||
| 20 | PI | Invirase | Saquinavir (SQV) | Roche | 1997 | Withdrawn 2005 | |
| 21 | PI | Norvir | Ritonavir (RTV) | Abbott | 2000 | ||
| 22 | PI | Agenerase | Amprenavir (APV) | GSK | 1997 | Withdrawn 2007 | |
| 23 | PI | - | Lopinavir (LPV) | - | 2000 | ||
| 24 | PI | Kaletra | Lopinavir (LPV)+Ritonavir (RTV) | Abbott | 2005 | 2 PI | |
| 25 | PI | Reyataz | Atazanavir (ATV) | BMS | 2003 | ||
| 26 | PI | Lexiva | Foseamprenavir | GSK | 2003 | ||
| 27 | PI | Prezista | Darunvir ethanolate | Tibotec | 2006 | ||
| 28 | PI | Aptivus | Tipranavir (TPV) | BI | 2005 | ||
| 29 | Fusion Inhibitor | Fuzeon | Enfuvirtide (T-20) | Roche | 2003 | ||
| 30 | Entry Inhibitors-CCR5 co-receptor antagonist | Selzentry | Maraviroc | Pfizer | 2007 | ||
| 31 | HIV integrase strand transfer inhibitors | Isentress | Raltegravir Potassium | Merck | 2007 | ||